2023

1. Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

   Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 5, pp. 1004-1016